financetom
Business
financetom
/
Business
/
Take-Two Interactive forecasts Q2 bookings below estimates on soft gaming spends
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Take-Two Interactive forecasts Q2 bookings below estimates on soft gaming spends
Aug 8, 2024 1:31 PM

(Reuters) -Videogame publisher Take-Two Interactive Software ( TTWO ) forecast second-quarter bookings below Wall Street expectations on Thursday, a sign of sluggish spending on its popular titles such as "Grand Theft Auto" and "NBA 2K" in an uncertain economy.

The downbeat projection highlights weakness in in-game spending on live-service titles as customers cut back on discretionary purchases amid a cost-of-living crisis and still-high inflation.

The company expects bookings to be between $1.42 billion and $1.47 billion for the second quarter, while analysts on average estimate $1.47 billion, according to LSEG data.

It, however, expects to see sequential growth in its net bookings in fiscals 2026 and 2027.

"Grand Theft Auto" is one of Take-Two's most popular properties, with the franchise having accumulated billions of dollars in revenue since its inception in the late-nineties.

The company in May narrowed the release window for the highly anticipated "Grand Theft Auto VI" to fall of 2025, setting the stage for the launch of the next installment of one of the most popular video game franchises in the world.

The company reported first-quarter bookings of $1.22 billion, missing analysts' estimate of $1.25 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aptevo Shares Decline After Pricing of $2.8 Million Stock Offering
Aptevo Shares Decline After Pricing of $2.8 Million Stock Offering
Jun 28, 2024
01:48 PM EDT, 06/28/2024 (MT Newswires) -- Aptevo Therapeutics ( APVO ) was down nearly 38% in recent Friday trading after it priced a share offering to raise about $2.8 million. The company said it entered agreements with certain healthcare-focused and institutional investors to buy more than 5.3 million shares at $0.515 each, bundled with warrants to buy up to...
US urges dismissal of lawsuit seeking menthol cigarette ban
US urges dismissal of lawsuit seeking menthol cigarette ban
Jun 28, 2024
June 28 (Reuters) - The Biden administration asked a federal judge to dismiss a lawsuit by anti-smoking groups demanding that it end nearly a year of delay and ban menthol cigarettes, which are used disproportionately by Blacks and younger people. In a Thursday night court filing, the Food and Drug Administration said the delay was not unreasonable because it had...
Biden-Trump debate draws 48 million TV viewers
Biden-Trump debate draws 48 million TV viewers
Jun 28, 2024
NEW YORK, June 28 (Reuters) - Roughly 48 million TV viewers tuned in to watch Thursday's U.S. presidential debate between Democratic President Joe Biden and Republican rival Donald Trump, according to preliminary Nielsen data. The numbers suggest the final audience will be about one-third lower than the 73 million people who watched the candidates' first face-off in 2020. The relatively...
Why Are Carisma Therapeutics Shares Surging Friday?
Why Are Carisma Therapeutics Shares Surging Friday?
Jun 28, 2024
Carisma Therapeutics Inc. ( CARM ) shares are trading higher on Friday following the company’s announcement of a significant development in its collaboration with Moderna. What To Know: Carisma has nominated its first in vivo CAR-M development candidate targeting Glypican-3 (GPC3) for the treatment of solid tumors, including hepatocellular carcinoma (HCC). This milestone has triggered a $2 million payment to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved